Former Liberal health minister Greg Hunt, who oversaw Australia’s response to the COVID-19 pandemic, has been appointed to the board of a private Sydney company developing drugs to combat rare blood diseases.
HaemaLogiX chief executive Damian Clarke-Bruce said in a press release that Mr Hunt’s appointment “further links us internationally with key industry stakeholders”.
Loading...
Aaron Patrick is the senior correspondent. He writes about politics and business from the Sydney newsroom. Email Aaron at apatrick@afr.com
